Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review.

Giovanni LandoniOlivia BelloniGiada Russo Alessandra BonaccorsoGianmarco CaràMatthieu Jabaudon

Published in: Journal of clinical medicine (2022)

Isoflurane was the most frequently used volatile agent in COVID-19 patients and allowed a reduction in the use of other sedative and analgesic drugs. Randomized evidence is building up and will be useful to confirm or challenge these findings.

Keyphrases

sars cov
double blind
open label
intensive care unit
acute respiratory distress syndrome
placebo controlled
cystic fibrosis
phase iii
mechanical ventilation
neuropathic pain
phase ii
anti inflammatory
gas chromatography
spinal cord
randomized controlled trial
spinal cord injury
extracorporeal membrane oxygenation